What Is BLCR? iShares Large Cap Core Active ETF

Approximate weights as of October 2026; refresh quarterly from iShares's fund page. Each ticker links to its individual stock guide in Walnut.

In August 2026 Apple did not appear in the ten largest positions of this US large-cap core fund, which is an unusual thing to be able to write. By October it was back, sixth at 4.6%. Microsoft has also moved up, from 3.9% to 6.5% and second place behind NVIDIA at 7.3%. Both moves pull the top of the portfolio closer to what a cap-weighted index looks like, although Apple is still held below the weight an index would give it.

The additions remain telling. ATI, a specialty metals company supplying the aerospace and defence industry, is held at 3.1%. Cardinal Health, a pharmaceutical distributor, is at 3.5%. Micron at 3.5% is a semiconductor manufacturer held far above its index weight, though trimmed from 4.4% in August. Intel, at 3.5% in August, has dropped out of the top ten. These are the positions where the manager is taking real risk relative to a benchmark, and they explain the 13% industrials weighting, which sits above the S&P 500's.

Taken together, the top ten is 48.8% of the fund. That is concentrated for a core equity holding, and the concentration is not simply an echo of the index's own top-heaviness. It reflects deliberate position sizing in mid-sized companies alongside the megacaps.

There is no index behind this fund, so the composition described here is a snapshot rather than a rule. The change between August and October 2026, with Apple returning to the top ten and Intel leaving it, is exactly the kind of rotation that can happen at any time. That is the product being purchased, and it changes how the position should be monitored: an index fund can be checked once a year, while an active fund's exposures need periodic review because the reason you bought it may no longer be in the portfolio.

The 0.36% fee sits at the low end for active management and at the high end relative to index funds covering the same universe, which cost a small fraction of it. That gap is a hurdle the manager has to clear annually. In US large caps specifically, that hurdle has historically been difficult to clear consistently, because the segment is heavily researched and information advantages are hard to sustain.

The 2023 launch means there is not enough history to draw conclusions from results. As of 2026-10-16 the share price was up 15.6% year to date and 24.9% over one year, with most of that gain earned before July: the price was down 0.4% over the latest three months. Assets have grown from $6.4B in August to $9.2B. What can be assessed is whether the portfolio is genuinely differentiated, and on that measure it still is. Underweight Apple, overweight Micron and Cardinal Health, holding a specialty metals company at 3.1%, this is not a closet index fund, which at least means the fee is buying something real.

The 0.32% yield is strikingly low for a large blend fund. It follows from the composition: NVIDIA, Amazon, Alphabet and Meta pay little or nothing relative to their size, and several of the other large positions are in companies reinvesting heavily. An investor drawing income from their portfolio would need to source it elsewhere entirely.

The sector shape as of October 2026 is technology at 38%, industrials at 13%, communication services at 11%, consumer discretionary at 10%, financials at 10% and healthcare at 9%. The technology figure is roughly in line with the broad US market, but the industrials weight is an overweight and the financials weight is on the lighter side. Those tilts, more than the individual stock picks, are likely to drive much of the divergence from a benchmark.

As a portfolio component, it works as a core US equity position for someone who wants active management, or as a satellite beside an index fund for someone who wants a measured amount of it. What does not work well is holding it alongside a large-cap index fund in similar size, which blends the active bets back toward index weights while still paying the active fee.

There are three common ways to get BLCR exposure. Buy shares (or fractional shares) of BLCR directly at any major broker that lists it. Hold it as a core position and layer more concentrated ideas on top. Or build it into a thematic portfolio in Walnut, so BLCR sits alongside other holdings that express the same thesis, with target weights you can rebalance toward. BLCR trades like a stock during market hours, so you buy it the same way you would any listed share.

New to buying funds? See how to buy an ETF, step by step.

Whether BLCR is a good buy depends less on any single call and more on your time horizon and what you already hold: it tracks Actively managed, no tracked index, so the real question is whether you want that exposure in your mix and at what weight. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is BLCR a buy?

BLCR gives you Actively managed, no tracked index exposure in one ticker at a 0.36% expense ratio. Most investors use it as a core holding and layer more concentrated thematic portfolios on top.

Whether BLCR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is BLCR a buy?

BLCR yields 0.32% as of October 2026, paid by passing through the dividends of its underlying holdings. For the payout schedule, history, and how the distributions are taxed, see BLCR dividend: yield and schedule.

For what analysts expect from the companies BLCR holds, its yield as a guide to income, and why no one publishes a price target for the fund itself, see the BLCR forecast.

New to funds like BLCR? Start with what an ETF is, then how to buy an ETF, or browse the full guide to ETF investing.